Business description: C-Rad AB

C-Rad AB is a Sweden-based holding company active in the medical equipment industry. It offers products and solutions to the radiation therapy market. C-Rad AB is the parent company within the C-Rad group (the Group). The Group provides such products, as Sentinel, a surface contour laser scanning system for patient positioning, monitoring and gating applications; Catalyst, a surface scanning system, which allows the identification and tracking of markers, and GEMini, a system based on a gaseous detector using metal converters interleaved with Gas Electron Multipliers (GEMs), as well as other products. The Company operates through several subsidiaries: C-RAD Positioning AB, C-RAD Imaging AB, C-RAD Innovation AB and Cyrpa International Sprl. The Company’s largest shareholder is Inter Life Science AB.

Number of employees: 98

Sales by Activity: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

Positioning

261M 301M 425M 469M 442M

Geographical breakdown of sales: C-Rad AB

Fiscal Period: December 2021 (SEK) 2022 (SEK) 2023 (SEK) 2024 (SEK) 2025 (SEK)

EMEA (Excluding Sweden)

- - - - 168M

APAC

- - 119M 210M 167M

Americas

- - 85.97M 72.7M 98.75M

Sweden

21.73M 8.67M - - 8.57M

South and Latin America

655K 689K - - -

Dach (Germany, Austria, Switzerland)

40.6M 31.88M - - -

The Rest of The Nordic Countries

5.37M 12.11M - - -

EMEA

- - 220M 186M -

France

13.91M 15.27M - - -

ROE (Other Europe)

46.27M 77.98M - - -

Asia

82.07M 83.99M - - -

USA

50.55M 70.75M - - -

Executive Committee: C-Rad AB

Manager TitleAgeSince
Chief Executive Officer 56 01/02/2026
Chief Executive Officer 49 20/10/2025
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer 50 -
Corporate Officer/Principal 52 31/03/2026

Composition of the Board of Directors: C-Rad AB

Director TitleAgeSince
Director/Board Member 52 31/12/2016
Director/Board Member 60 06/05/2021
Chairman 61 04/05/2023
Director/Board Member 60 04/05/2023
Director/Board Member 66 04/05/2023
Director/Board Member 55 22/07/2007

Shareholders: C-Rad AB

NameStocks%Valuation
Svea Bank AB
11.93 %
3,924,969 11.93 % 9 M kr
9.926 %
3,266,170 9.926 % 8 M kr
Cervantes Capital AB
9.521 %
3,132,758 9.521 % 7 M kr
5.197 %
1,710,018 5.197 % 4 M kr
4.863 %
1,600,000 4.863 % 4 M kr
NameStocks%Valuation
44.01 %
379,762 44.01 % 896 098 kr
30.49 %
263,125 30.49 % 620 878 kr
Cervantes Capital AB
13.91 %
120,000 13.91 % 283 156 kr
Svea Bank AB
11.59 %
100,000 11.59 % 235 963 kr

Holdings: C-Rad AB

NameStocks%Valuation
785,5002.39% 2 M $

Company details: C-Rad AB

C-RAD AB

Sjukhusvaegen 12K

753 09, Uppsala

+46 18 666 930

http://www.c-rad.com
address C-Rad AB(CRAD B)

Other Advanced Medical Equipment & Technology

Change 5-day change 1-year change 3-year change Capi.($)
-1.69%-6.83%-32.85%-40.44% 76.7M
-2.79%-4.38%+16.90%+42.75% 248B
-3.16%-5.43%-0.82%+4.42% 155B
-2.01%-10.04%-27.74%+28.17% 138B
-2.35%-5.32%-56.54%-22.92% 60.85B
-1.95%-4.95%+21.12%+51.59% 58.56B
-1.96%-2.25%+4.04%-14.08% 52.46B
-2.83%-2.06%+17.45%+49.48% 48.04B
-3.51%-4.30%+16.33%+68.80% 43.29B
+1.26%-11.71%-1.58%+48.97% 43.1B
Average -2.10%-4.48%-4.37%+21.67% 85B
Weighted average by Cap. -2.42%-3.87%-0.34%+27.76%
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - C-Rad AB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
23.20SEK
Average target price
35.00SEK
Spread / Average Target
+50.86%